Heath Lukatch - 24 Oct 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
Director
Signature
Heath Lukatch, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
24 Oct 2022
Transactions value $
-$146,617
Form type
4
Filing time
26 Oct 2022, 17:54:01 UTC
Previous filing
07 Jun 2022
Next filing
15 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $48.2K +3.02K +96.48% $16.00 6.14K 24 Oct 2022 Direct
transaction PCVX Common Stock Sale -$106K -3.02K -49.1% $35.11 3.13K 24 Oct 2022 Direct F1
transaction PCVX Common Stock Options Exercise $64K +4K +128% $16.00 7.13K 26 Oct 2022 Direct
transaction PCVX Common Stock Sale -$153K -4K -56.14% $38.25 3.13K 26 Oct 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Disposed to Issuer $0 -3.02K -7.54% $0.00 37K 24 Oct 2022 Common Stock 3.02K $16.00 Direct F2
transaction PCVX Stock Option (right to buy) Disposed to Issuer $0 -4K -10.82% $0.00 33K 26 Oct 2022 Common Stock 4K $16.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 1/3 of the shares subject to the option vest on June 11, 2021, and 1/36 of the shares vest monthly thereafter.